Predictors of seizure-free outcome after epilepsy surgery for pediatric tuberous sclerosis complex

Pavel Krsek1, Alena Jahodova, Martin Kyncl

  • 1Department of Pediatric Neurology, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic.

Epilepsia
|October 15, 2013
PubMed

Insights

Predictors of seizure freedom after epilepsy surgery in children with tuberous sclerosis complex (TSC) were identified. Complete removal of epileptogenic tissue and specific EEG patterns are key to successful surgical outcomes in pediatric TSC patients.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neurosurgery

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder associated with epilepsy.
  • Predicting seizure outcomes after epilepsy surgery in pediatric TSC patients is challenging.
  • Identifying prognostic factors is crucial for optimizing surgical selection and management.

Purpose of the Study:

  • To identify prognostic factors for seizure outcome in children with TSC undergoing epilepsy surgery.
  • To enhance patient selection for epilepsy surgery in pediatric TSC.

Main Methods:

  • Retrospective review of 33 pediatric TSC patients who underwent excisional epilepsy surgery.
  • Analysis of 29 clinical, neuropsychological, EEG, MRI, and surgical variables.
  • Statistical analysis using Barnard's exact test, Wilcoxon's rank-sum test, and Cox's model.

Main Results:

  • 55% of patients were seizure-free at 2 years post-surgery; 15% experienced complications.
  • Complete removal of epileptogenic tissue (MRI/intracranial EEG), specific scalp EEG patterns, and concordant EEG localization predicted seizure freedom.
  • Fewer tubers, preoperative hemiparesis, and one-stage surgery were also significant predictors.

Conclusions:

  • Perioperative factors, not preoperative variables, are the primary determinants of seizure outcome in pediatric TSC epilepsy surgery.
  • Findings can aid in surgical decision-making for TSC patients.
  • Optimizing surgical techniques and targeting epileptogenic zones are critical for improving outcomes.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
73
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
43
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K